Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yujin Hoshida

Showing results (251-260 of 264) with videos related to

Pageof 27
Sort By:
Gastroenterology|April 13, 2019
Combined Analysis of Metabolomes, Proteomes, and Transcriptomes of Hepatitis C Virus-Infected Cells and Liver to Identify Pathways Associated With Disease DevelopmentJoachim Lupberger, Tom Croonenborghs, Armando Andres Roca Suarez, et al.
Cell Metabolism|September 25, 2018
Inhibition of Acetyl-CoA Carboxylase by Phosphorylation or the Inhibitor ND-654 Suppresses Lipogenesis and Hepatocellular CarcinomaJames S V Lally, Sarani Ghoshal, Danielle K DePeralta, et al.
Nature|October 5, 2022
Opposing roles of hepatic stellate cell subpopulations in hepatocarcinogenesisAveline Filliol, Yoshinobu Saito, Ajay Nair, et al.
Journal of Hepatology|October 29, 2022
Treatment of HCC with claudin-1-specific antibodies suppresses carcinogenic signaling and reprograms the tumor microenvironmentNatascha Roehlen, Marion Muller, Zeina Nehme, et al.
Nature Genetics|September 6, 2011
Genomic sequencing of colorectal adenocarcinomas identifies a recurrent VTI1A-TCF7L2 fusionAdam J Bass, Michael S Lawrence, Lear E Brace, et al.
Science Translational Medicine|June 22, 2022
Molecular signatures of long-term hepatocellular carcinoma risk in nonalcoholic fatty liver diseaseNaoto Fujiwara, Naoto Kubota, Emilie Crouchet, et al.
Nature|July 31, 2025
ACLY inhibition promotes tumour immunity and suppresses liver cancerJaya Gautam, Jianhan Wu, James S V Lally, et al.
Science Translational Medicine|December 21, 2022
A monoclonal antibody targeting nonjunctional claudin-1 inhibits fibrosis in patient-derived models by modulating cell plasticityNatascha Roehlen, Antonio Saviano, Houssein El Saghire, et al.
Cancer Cell|December 14, 2016
Molecular Liver Cancer Prevention in Cirrhosis by Organ Transcriptome Analysis and Lysophosphatidic Acid Pathway InhibitionShigeki Nakagawa, Lan Wei, Won Min Song, et al.
Nature|March 13, 2025
Hepatic stellate cells control liver zonation, size and functions via R-spondin 3Atsushi Sugimoto, Yoshinobu Saito, Guanxiong Wang, et al.
Pageof 27

Showing results (251-260 of 264) with videos related to

Sort By:
Pageof 27
Gastroenterology|April 13, 2019
Combined Analysis of Metabolomes, Proteomes, and Transcriptomes of Hepatitis C Virus-Infected Cells and Liver to Identify Pathways Associated With Disease DevelopmentJoachim Lupberger, Tom Croonenborghs, Armando Andres Roca Suarez, et al.
Cell Metabolism|September 25, 2018
Inhibition of Acetyl-CoA Carboxylase by Phosphorylation or the Inhibitor ND-654 Suppresses Lipogenesis and Hepatocellular CarcinomaJames S V Lally, Sarani Ghoshal, Danielle K DePeralta, et al.
Nature|October 5, 2022
Opposing roles of hepatic stellate cell subpopulations in hepatocarcinogenesisAveline Filliol, Yoshinobu Saito, Ajay Nair, et al.
Journal of Hepatology|October 29, 2022
Treatment of HCC with claudin-1-specific antibodies suppresses carcinogenic signaling and reprograms the tumor microenvironmentNatascha Roehlen, Marion Muller, Zeina Nehme, et al.
Nature Genetics|September 6, 2011
Genomic sequencing of colorectal adenocarcinomas identifies a recurrent VTI1A-TCF7L2 fusionAdam J Bass, Michael S Lawrence, Lear E Brace, et al.
Science Translational Medicine|June 22, 2022
Molecular signatures of long-term hepatocellular carcinoma risk in nonalcoholic fatty liver diseaseNaoto Fujiwara, Naoto Kubota, Emilie Crouchet, et al.
Nature|July 31, 2025
ACLY inhibition promotes tumour immunity and suppresses liver cancerJaya Gautam, Jianhan Wu, James S V Lally, et al.
Science Translational Medicine|December 21, 2022
A monoclonal antibody targeting nonjunctional claudin-1 inhibits fibrosis in patient-derived models by modulating cell plasticityNatascha Roehlen, Antonio Saviano, Houssein El Saghire, et al.
Cancer Cell|December 14, 2016
Molecular Liver Cancer Prevention in Cirrhosis by Organ Transcriptome Analysis and Lysophosphatidic Acid Pathway InhibitionShigeki Nakagawa, Lan Wei, Won Min Song, et al.
Nature|March 13, 2025
Hepatic stellate cells control liver zonation, size and functions via R-spondin 3Atsushi Sugimoto, Yoshinobu Saito, Guanxiong Wang, et al.
Pageof 27